Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas)

Laryngoscope

Volumn 108, Issue 2, 1998, Pages 178-189

  Welling, D Bradley ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; CRANIAL NERVE TUMOR; FACIAL NERVE PARALYSIS; FEMALE; GENE MUTATION; GENETIC SCREENING; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NEUROFIBROMA; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; GENES, NEUROFIBROMATOSIS 2; GENETIC SCREENING; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; NEUROFIBROMATOSIS 2; NEUROFIBROMIN 2; PEDIGREE; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0031929738     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199802000-00005     Document Type: Article

References (63)

1. Tos M, Thomsen J, Charabi S. Epidemiology of acoustic neuroma: has the incidence increased during the last years? In: Tos M, Thomsen J, eds. Proceedings of the 1st International Conference on Acoustic Neuroma. Amsterdam: Kugler, 1992:3-6.
2. Fontaine B, Rouleau GA, Seizinger BR, et al. Molecular genetics of neurofibromatosis 2 and related tumors (acoustic neuroma and meningioma). Ann N Y Acad Sci 1991;615:338-43.
3. Martuza RL, Eldridge R. Neurofibromatosis 2. N Engl J Med 1988;318:684-8.
4. Evans DG, Hudson SM, Donnai D, et al. A genetic study of type-2 neurofibromatosis in the United Kingdom. Part I. Prevalence, mutation rate, fitness and confirmation of maternal transmission effect on severity. J Med Genet 1992;29:841-6.
5. Mautner VF, Tatagiba M, Guthoff R, Samii M, Pulst SM. Neurofibromatosis 2 in the pediatric age group. Neurosurgery 1993;33(1):92-6.
6. Kanter W, Eldrige R. Evidence of a maternal effect in central neurofibromatosis. Lancet 1978;2:903.
7. Evans DG, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. Part II. Guidelines for genetic counseling. J Med Genet 1992;29:847-52.
8. Wishart JH. Case of tumors in the skull, dura mater, and brain. Edinburgh Med Surg J 1922;18:393-7.
9. Gardner WJ, Frazier CH. Bilateral acoustic neurofibromatosis: a clinical study and field survey of a family of five generations with bilateral deafness in thirty-eight members. Arch Neurol Psychiatry 1930;23:266-302.
10. Short MP, Martuza RL, Huson SM. Neurofibromatosis 2: clinical features, genetic counseling and management issues. In: Huson SM, Hughes RAC, eds. The Neurofibromatoses: A Pathogenetic and Clinical Overview. London: Chapman & Hall Medical; 1994:414-44.
11. Acoustic neuroma. NIH Consens Statement 1991;9(4):1-24.
12. von Recklinghausen F. Ueber die Multiplen Fibrome der Haut und ihre Bezlehung zu den Multiplen Neuromen. Berlin: A. Hirschundel; 1882.
13. Cushing H. Aged Tumors of the Nervus Acusticus and the Syndrome of the Cerebellopontine Angle. New York and London: Hafner Publishing; 1917.
14. Dandy WE. Ventriculography following the injection of air into the cerebral ventricles. Ann Surg 1918;68:5.
15. Cushing H: The acoustic tumors. In: Intracranial Tumors. Springfield, IL: Charles C. Thomas; 1932;85-92.
16. House WF. Surgical exposure of the internal auditory canal and its contents through the middle cranial fossa. Laryngoscope 1961;71:1353-85.
17. Sobel RA. Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases. J Neuropathol Exp Neurol 1993;52:106-113.
18. Jacoby LB, Pulaski K, Rouleau GA, Martuza RL. Clonal analysis of human meningiomas and schwannomas. Cancer Res 1990;50:6783-6.
19. Lesser T, Janzer R, Kleinhues P, Fisch U. Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody Ki-67. Skull Base Surg 1991;1:11-5.
20. Seizinger BR, Martuza RL, Gusella JF. Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 1986;322:644-7.
21. Seizinger, BR, Rouleau GA, Ozelius LJ, et al. Common pathogenetic mechanism for three types in bilateral acoustic neurofibromatosis. Science 1987;236:317-9.
22. Wertelecki W, Rouleau GA, Superneau DW, et al. Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med 1988;319(5):278-83.
23. Narod SA, Parry DM, Parboosingh J, et al. Neurofibromatosis type 2 appears to be a genetically homogeneous disease. Am J Hum Genet 1992;51:486-96.
24. Arai E, Ikeuchi T, Karasawa S, et al. Constitutional translocation t(4;22) (q12;112.2) associated with neurofibromatosis type 2. Am J Med Genet 1992;44:163-7.
25. Arai E, Tokino T, Imai T, et al. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF 2. Genes Chromosom Cancer 1993;6:235-8.
26. Wolff RK, Frazer KA, Jackler RK, Lanser MJ, Pitts LH, Cox DR. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genet 1992;51:478-85.
27. Seizinger BR, de la Monte S, Atkins L, Gusella JF, Martuza RL. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A 1987;84:5419-23.
28. Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S. Cytogenetic analysis in human neurinomas. Cancer Genet Cytogenet 1987;28:187-8.
29. Wullich B, Kiechle-Schwarz M, Mayfrank L, Schempp W. Cytogenetic and in situ DNA-hybridization studies in intracranial tumors of a patient with central neurofibromatosis. Hum Genet 1989;82:31-4.
30. Couturier J, Delattre O, Kujas M, et al. Assessment of chromosome 22 anomalies in neurinomas by combined karyotype and RFLP analysis. Cancer Genet Cytogenet 1990;45: 55-62.
31. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800.
32. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organising protein causes neurofibromatosis type 2. Nature 1993;363:515-21.
33. Sato N, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. A gene family consisting of ezrin, radixin and moesin: its specific localization at actin filament/plasma membrane association sites. J Cell Sci 1992;103:131-43.
34. Louis DN, Ramesh V, Gusella JF. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 1995;5:163-72.
35. Thompson MW, McInnes RR, Willard HF. Genetics in Medicine, edn 5. Philadelphia: WB Saunders; 1991:90-2.
36. Knudson AG. Mutation and cancer: a statistical study. Proc Natl Acad Sci U S A 1971;68:820-3.
37. Moffat DA, Irving R. The molecular genetics of vestibular schwannoma. J Laryngol Otol 1995;109:381-4.
38. Lutchman M, Rouleau GA. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res 1995;55(11):2270-4.
39. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 1994;3:885-91.
40. Bijlsma EK, Merel P, Bosch DA, et al. Analysis of mutations in the SCH gene in schwannomas. Genes Chromosom Cancer 1994;11:7-14.
41. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Somatic NF2 gene mutation in familial and non-familial vestibular schwannomas. Hum Mol Genet 1994;3:347-50.
42. Jacoby LB, MacCollin M, Louis DN, et al. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994;3:413-9.
43. Bourn D, Evans G, Mason S, Tekes S, Trueman L, Strachan T. Eleven novel mutations in the NF2 tumour suppressor gene. Hum Genet 1995;95:572-4.
44. Merel P, Hoang-Xuan K, Sanson M, et al. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosom Cancer 1995;13: 1211-6.
45. Welling DB, Guida M, Goll F, et al. Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas. Hum Genet 1996;98(9):189-93.
46. MacCollin M, Ramesh V, Jacoby LB, et al. Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 1994;55:314-20.
47. Merel P, Hoang-Xuan K, Sanson M, et al. Screening for Germ-Line Mutations in the NF2 Gene. Genes Chromosom Cancer 1995;12:117-27.
48. Ruttledge MH, Andermann AA, Phelan CM, et al. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 1996;59:331-42.
49. Mautner VF, Baser ME, Kluwe L. Phenotypic variability in two families with novel splice-site and frameshift NF2 mutations. Hum Genet 1996;98:203-6.
50. Grompe M. The rapid detection of unknown mutations in nucleic acids. Nat Genet 1993;5:111-7.
51. Youssoufian H, Kazazian HH, Phillips DG, et al. Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature 1986;324:380-2.
52. Sainz J, Figueroa K, Baser ME, Mautner VF, Pulst SM. High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA codons. Hum Mol Genet 1995;4:137-9.
53. Howard M, Frizzell RA, Bedwell DM. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nature Med 1996;2(4):467-9.
54. Twist EC, Ruttledge MH, Rousseau M, et al. The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 1994;3:147-51.
55. Welling DB, Glasscock ME. The diagnostic work-up of acoustic neuromas. In: Tos M, Thomsen J, eds. Acoustic Neuroma. Amsterdam and New York: Kugler; 1991:101-5.
56. American Medical Association. Ear, nose, throat, and related structures. In: Guides to the Evaluation of Permanent Impairment, edn 3. Chicago: American Medical Association; 1991:173-9.
57. MacCollin M, Mohney T, Trofatter J, Wertelecki W, Ramesh V, Gusella J. DNA diagnosis of neurofibromatosis 2. JAMA 1993;270(19):2316-20.
58. Evans DG, Bourn D, Wallace A, Ramsden RT, Mitchell JD, Strachan T. Diagnostic issues in a family with late onset type 2 neurofibromatosis. J Med Genet 1995;32:470-4.
59. Thompson MW, McInnes RR, Willard HF. Genetics in Medicine, edn 5. Philadelphia: WB Saunders; 1991:427-42.
60. Shannon RV, Portillo F. Auditory brainstem implant. In: Jackler RK, Brackmann DE, eds. Neurotology. St. Louis: Mosby; 1994:1387-95.
61. Hoffman RA, Kohan D, Cohen NL. Cochlear implants in the management of bilateral acoustic neuromas. Am J Otol 1992;13:525-9.
62. Deperez RHL, Blanchi AB, Groen NA, et al. Frequent NF 2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 1994;54: 1022-9.
63. Miyamoto RT, Roos KL, Campbell RL. The neurofibromatoses. In: Jackler RK, Brackmann DE, eds. Neurotology. St. Louis: Mosby; 1994.